MedicarePartD.guide

A non-government resource built from CMS public data

Osteoporosis drugs on every 2026 Kansas Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Kansas cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

Osteoporosis drugs by 2026 Kansas Part D plan
DrugBlue MedicareRx Essentials$0.00/moS5726-020Blue MedicareRx Value$0.70/moS5726-013HealthSpring Assurance Rx$6.70/moS5617-118Wellcare Value Script$9.60/moS4802-157Wellcare Classic$14.70/moS4802-088Humana Basic Rx Plan$15.50/moS5884-109Humana Value Rx Plan$55.60/moS5884-203Blue MedicareRx Plus$67.40/moS5726-014SilverScript Choice$88.30/moS5601-048AARP Medicare Rx Saver from UHC$105.40/moS5921-369Humana Premier Rx Plan$116.30/moS5884-170AARP Medicare Rx Preferred from UHC$147.00/moS5921-405
alendronategeneric FosamaxTier 1$0.00QL 120/30dTier 1$0.00QL 120/30dTier 15%QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 2$1.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00QL 120/30dTier 1$0.00Tier 2$7.00QL 30/30dTier 1$0.00QL 30/30dTier 1$5.00QL 30/30d
risedronategeneric ActonelTier 2$0.00QL 1/28dNot coveredNot coveredTier 2$3.00QL 1/30dNot coveredNot coveredNot coveredTier 320%QL 1/28dTier 433%QL 1/28dNot coveredNot coveredNot covered
ibandronategeneric BonivaTier 2$0.00QL 1/28dTier 2$2.00QL 1/28dTier 325%QL 1/28dTier 2$3.00QL 1/30dTier 325%QL 1/30dTier 325%QL 1/28dTier 320%QL 1/28dTier 2$0.00QL 1/28dTier 433%QL 1/30dTier 317%QL 1/28dTier 3$45.00QL 1/28dTier 315%QL 1/28d
ProliadenosumabNot coveredNot coveredTier 431%QL 1/180dNot coveredNot coveredTier 435%QL 1/180dTier 432%QL 1/180dNot coveredNot coveredNot coveredTier 450%QL 1/180dNot covered
denosumab biosimilarsJubbonti, Ospomyv and othersTier 4PA30%Tier 4PA40%Not coveredTier 440%QL 1/180dTier 426%QL 1/180dNot coveredNot coveredTier 4PA40%Tier 433%QL 1/180dTier 438%QL 1/180dNot coveredTier 438%QL 1/180d
EvenityromosozumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ForteoteriparatideNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 2.24/28dTier 5PA26%QL 2.24/28dNot coveredNot coveredNot coveredTier 5PA33%QL 2.24/28dNot covered
teriparatidegeneric ForteoTier 5PA25%Not coveredTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dNot coveredNot coveredTier 5PA33%Tier 5PA25%Tier 5PA25%QL 2.48/28dNot coveredTier 5PA31%QL 2.48/28d
TymlosabaloparatideTier 5PA25%Tier 5PA25%Not coveredNot coveredNot coveredNot coveredNot coveredTier 5PA33%Tier 5PA25%Not coveredNot coveredTier 5PA31%QL 1.56/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.